FDA approves a new molecular entity, Kuvan, to treat phenylketonuria.
Orphan drug gets FDA nod for phenylketonuria
Submitted by eport on Mon, 02/11/2008 - 05:00.
»
- Login or register to post comments
- Feed: New Rx: Drug Topics
- Original article